Diagnostic utility of plasma p‐tau217 differs by Alzheimer's disease tau‐based subtypes
Seyed Hani Hojjati, Tracy Butler, Shahram Zare, Ali Reihanian et autres
Introduction: Blood-based biomarkers, most notably plasma phosphorylated tau (p-tau)217, have transformed the diagnostic landscape of Alzheimer's disease (AD). Methods: We applied an unsupervised machine learning approach to tau positron emission tomography (PET) imaging in 606 participants (age 73.95 ± 7.72; 309 female) …
us, ir (code pays fourni par la source)